trending Market Intelligence /marketintelligence/en/news-insights/trending/tqywpfz8eopk8lhtr7z9ba2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Scythian Biosciences adds board member

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Scythian Biosciences adds board member

Scythian Biosciences Corp. appointed Andrew DeFrancesco to its board of directors, effective Sept. 4.

DeFrancesco is chairman of Cool Holdings Inc., a Nasdaq-listed investment company.

Toronto-based Scythian Biosciences develops cannabis-derived treatments for concussions and traumatic brain injuries.